Empatab M 5/500DescriptionEmpagliflozin is an inhibitor of Sodium-glucose co-transporter 2 (SGLT2). By inhibiting SGLT2, Empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.IndicationsEmpagliflozin is..
Empa Met 5 mg+500 mg Tablet, 1 BoxDescription:Empagliflozin is an inhibitor of Sodium-Glucose Co-Transporter 2 (SGLT2). SGLT2 is the predominant transporter, responsible for reabsorption of glucose from the kidney back into the circulation. By inhibiting SGLT2, Empagliflozin reduces renal reabsorpti..
Emjard M 5/500 mg TabletIndication:Emjard™ M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetesDosage & Administration:Starting dose of Emjard™ M should be individualized based on the patient’s current regimen.Recommended individ..
Jardimet 5/500 mg Tablet1. What is Jardimet®?Jardimet® is a combination of Empagliflozin, a Sodium-glucose cotransporter-2 (SGLT2) inhibitor and Metformin Hydrochloride, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus..